Vitebsk Regional Clinical Cancer Centre
1 clinical trials · Sponsor
◉ Watch Vitebsk Regional Clinical Cancer Centre
| Record | Firm | Date |
|---|---|---|
| Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients. (NCT06762431) | Vitebsk Regional Clinical Cancer Centre | 2024-05-14 |
Track Vitebsk Regional Clinical Cancer Centre automatically
Every clearance here is in the API, with alerts when new ones post.